| Literature DB >> 28701155 |
Karen Louise Ellekjaer1, Thomas Bergholt2, Ellen Løkkegaard3.
Abstract
BACKGROUND: Obesity is increasing among primipara women. We aimed to describe the association between body mass index (BMI) during early-pregnancy and duration of labour in nulliparous women.Entities:
Mesh:
Year: 2017 PMID: 28701155 PMCID: PMC5508690 DOI: 10.1186/s12884-017-1413-6
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Fig. 1Flow chart of patients who met inclusion/exclusion criteria for the study population. *Robson group 1 comprising nullipara, singleton cephalic ≥37 weeks in spontaneous labour, ** Robson group 2 comprising nullipara, singleton cephalic ≥37 weeks who were induced or underwent caesarean before labour, *** Robson group 2a comprising nullipara, singleton cephalic ≥37 weeks who had labour induced. **** Robson group 2b; comprising nullipara, singleton cephalic ≥37 weeks who underwent caesarean section before labour
Distribution of covariates at baseline among women in different body mass index groups
| Maternal BMI a: | ||||
|---|---|---|---|---|
| <25 | 25–29.9 | ≥30 | ||
| Covariates |
| ( | ( | ( |
| Maternal age |
| |||
| < 25 | 317 (25.4%) | 86 (24.6%) | 54 (26.6%) | |
| 25–30 | 429 (34.4%) | 126 (36.0%) | 74 (36.4%) | |
| 30–35 | 376 (30.2%) | 100 (28.5%) | 59 (29.1%) | |
| > 35 | 124 (10.0%) | 38 (10.9%) | 16 (7.9%) | |
| Height |
| |||
| < 160 cm | 124 (10.0%) | 36 (10.3%) | 15 (7.4%) | |
| 160-169 cm | 595 (47.7%) | 178 (50.9%) | 106 (52.2%) | |
| 170–179 cm | 477 (38.3%) | 124 (35.4%) | 73 (36.0%) | |
| ≥ 180 cm | 50 (4.0%) | 12 (3.4%) | 9 (4.4%) | |
| Hypertensive disease |
| |||
| No | 1132 (90.9%) | 271 (77.4%) | 158 (77.8%) | |
| Yes | 114 (9.1%) | 79 (22.6%) | 45 (22.2%) | |
| Gestational Diabetes |
| |||
| No | 1218 (97.8%) | 335 (95.7%) | 188 (92.6%) | |
| Yes | 28 (2.2%) | 15 (4.3%) | 15 (7.4%) | |
| Gestational age |
| |||
| 37–38 weeks | 173 (13.9%) | 46 (13.1%) | 36 (17.7%) | |
| 39–40 weeks | 635 (51.0%) | 180 (51.4%) | 98 (48.3%) | |
| ≥ 41 weeks | 438 (35.1%) | 124 (35.5%) | 69 (34.0%) | |
| Labour Induced |
| |||
| Yes | 363 (29.1%) | 131 (37.4%) | 98 (48.3%) | |
| No | 831 (70.9%) | 219 (62.6%) | 105 (51.7%) | |
| CTG |
| |||
| Yes | 906 (72.7%) | 285 (81.4%) | 176 (86.7%) | |
| No | 340 (27.3%) | 65 (18.6%) | 27 (13.3%) | |
| Oxytocin |
| |||
| Yes | 744 (59.7%) | 232 (66.3%) | 135 (66.5%) | |
| No | 502 (40.3%) | 118 (33.7%) | 68 (33.5%) | |
| Epidural analgesia |
| |||
| Yes | 501 (40.2%) | 170 (48.6%) | 114 (56.2%) | |
| No | 745 (59.8%) | 180 (51.4%) | 89 (43.8%) | |
| Birthweight |
| |||
| <3.0 kg | 187 (15.0%) | 41 (11.7%) | 11 (5.5%) | |
| 3.0–3.5 kg | 439 (35.3%) | 111 (31.8%) | 80 (39.8%) | |
| 3.5–4.0 kg | 456 (36.7%) | 141 (40.4%) | 69 (34.3%) | |
| >4.0 kg | 162 (13.0%) | 56 (16.1%) | 41 (20.4%) | |
Values are numbers (percentages)
86 women (4.5%) did not have BMI recorded and were therefore not accounted for in analysis
Cox regression showing the hazard ratio (HR) of vaginal birth in the defined body mass index (BMI) groups, with and without adjustment for covariates
| Total duration a | ||||
|---|---|---|---|---|
| Covariates | Crude HR | 95% CI | Adjusted HR | 95% CI |
| BMI | ||||
| < 25 | 1 | 1 | ||
| 25–29.9 | 0.83 | [0.73–0.96] | 1.01 | [0.88–1.16] |
| ≥ 30 | 0.94 | [0.78–1.12] | 1.07 | [0.90–1.28] |
| Height | ||||
| < 160 cm | 1 | 1 | ||
| 160–169 cm | 1.31 | [1.08–1.59] | 1.32 | [1.09–1.61] |
| 170–179 cm | 1.44 | [1.18–1.76] | 1.61 | [1.32–1.98] |
| ≥ 180 cm | 1.66 | [1.21–2.26] | 1.73 | [1.26–2.38] |
| Age | ||||
| < 25 | 1 | 1 | ||
| 25–29 | 0.87 | [0.77–0.99] | 1.04 | [0.91–1.19] |
| 30–34 | 0.82 | [0.72–0.94] | 0.97 | [0.84–1.11] |
| ≥ 35 | 0.62 | [0.51–0.77] | 0.68 | [0.54–0.84] |
| Birthweight | ||||
| < 3.0 kg | 1 | 1 | ||
| 3.0–3.5 kg | 0.77 | [0.66–0.90] | 0.66 | [0.56–0.78] |
| 3.5–4.0 kg | 0.53 | [0.46–0.62] | 0.49 | [0.42–0.58] |
| > 4.0 kg | 0.38 | [0.31–0.46] | 0.38 | [0.30–0.47] |
| Epidural | ||||
| No | 1 | 1 | ||
| Yes | 0.29 | [0.26–0.32] | 0.33 | [0.29–0.37] |
| Augmentation with oxytocin: | ||||
| No | 1 | 1 | ||
| Yes | 0.31 | [0.28–0.35] | 0.40 | [0.36–0.45] |
| Induced labour: | ||||
| No | 1 | 1 | ||
| Yes | 0.91 | [0.82–1.02] | 1.68 | [1.48–1.90] |
| Phase 1 | ||||
| Crude HR | 95% CI | Adjusted HR | 95% CI | |
| BMI | ||||
| < 25 | 1 | 1 | ||
| 25–29.9 | 0.99 | [0.86–1.14] | 1.11 | [0.96–1.28] |
| ≥ 30 | 1.01 | [0.85–1.21] | 1.04 | [0.86–1.24] |
| Phase 2 | ||||
| Crude HR | 95% CI | Adjusted HR | 95% CI | |
| BMI | ||||
| < 25 | 1 | 1 | ||
| 25–29.9 | 0.90 | [0.96–1.28] | 0.99 | [0.86–1.14] |
| ≥ 30 | 1.06 | [0.96–1.28] | 1.29 | [1.07–1.55] |
Phase 1 was defined as the period of time from active labour until the cervix was fully dilated
Phase 2 was defined as the period of time from when the cervix was fully dilated to the actual birth. Caesarean deliveries censored
A hazard ratio (HR) >1 indicates an increased number of vaginal deliveries over time compared to the reference group; a shorter duration of labour. A HR < 1 indicates a decreased number of vaginal deliveries over time compared to the reference group; a longer duration of labour
a77 women (4.1%) did not have duration measures recorded and were therefore not accounted for in analysis
Fig. 2Survival plot as a function of time from onset of active labour until vaginal delivery. Event was defined as delivery. Women were censored at the time of caesarean delivery. Adjustments were made for maternal age, height, birth weight, labour induction, augmentation with oxytocin, and epidural analgesia. A hazard ratio (HR) >1 illustrates a shorter duration of labour while a HR <1 illustrates a longer duration of labour compared to the reference group consisting of normal-weight women
Descriptive and logistic regression analysis regarding secondary outcome variables. Values of odds ratios are presented as crude estimates as well as after adjustment
| Secondary outcome variables |
| Crude OR | 95% CI | Adjusted OR | 95% CI | ||
|---|---|---|---|---|---|---|---|
| Total number of caesarean deliveries a | ( | No | Yes | ||||
| BMI < 25 | 1047 (84.0%) | 199 (16.0%) | 1 | 1 | |||
| BMI 25–29.9 | 258 (73.7%) | 92 (26.3%) | 1.88 | [1.42–2.49] | 1.62 | [1.18–2.22] | |
| BMI ≥ 30 | 141 (69.5%) | 62 (30.5%) | 2.31 | [1.66–3.23] | 1.76 | [1.20–2.58] | |
| Caesarean prior to onset of active labor a | ( | No | Yes | ||||
| BMI < 25 | 22 (1.8%) | 1211 (98.2%) | 1 | 1 | |||
| BMI 25–29.9 | 19 (5.4%) | 331 (94.6%) | 1.99 | [1.12–3.52] | 1.64 | [0.90–2.98] | |
| BMI ≥ 30 | 18 (8.9%) | 185 (91.1%) | 3.37 | [1.87–6.07] | 2.75 | [1.47–5.16] | |
| Reached 2nd stage of labour a | ( | No | Yes | ||||
| BMI < 25 | 134 (10.8%) | 1112 (89.2%) | 1 | 1 | |||
| BMI 25–29.9 | 66 (18.9%) | 284 (81.1%) | 1.85 | [1.38–2.48] | 0.61 | [0.45–0.84] | |
| BMI ≥ 30 | 48 (23.6%) | 155 (76.4%) | 2.13 | [1.50–3.03] | 0.59 | [0.40–0.85] | |
| Vacuum delivery b | ( | No | Yes | ||||
| BMI < 25 | 1068 (85.7%) | 178 (14.3%) | 1 | 1 | |||
| BMI 25–29.9 | 304 (86.9%) | 46 (13.1%) | 0.91 | [0.64–1.27] | 0.83 | [0.58–1.18] | |
| BMI ≥ 30 | 181 (89.2%) | 22 (10.8%) | 0.73 | [0.46–1.17] | 0.65 | [0.40–1.06] | |
| Post-partum haemorrhage ≥ 1000 mL c | ( | No | Yes | ||||
| BMI < 25 | 1176 (89.1%) | 70 (10.9%) | 1 | 1 | |||
| BMI 25–29.9 | 325 (92.9%) | 25 (7.1%) | 1.29 | [0.81–2.07] | 1.04 | [0.64–1.70] | |
| BMI ≥ 30 | 181 (89.2%) | 22 (10.8%) | 2.04 | [1.23–3.38] | 1.54 | [0.90–2.61] | |
| Arterial cord pH < 7.05 d | ( | No | Yes | ||||
| BMI < 25 | 1128 (98.4%) | 18 (1.6%) | 1 | ||||
| BMI 25–29.9 | 323 (97.9%) | 7 (2.1%) | 1.36 | [0.56–3.28] | |||
| BMI ≥ 30 | 187 (95.7%) | 8 (4.3%) | 2.85 | [1.22–6.65] |
aAdjustments made for: Age, height, birthweight, labour induction, epidural analgesia and use of oxytocin during labour
bAdjustments made for: Age and use of oxytocin during labour
cAdjustments made for: Birthweight, epidural analgesia and caesarean delivery
dNo Adjustments were made
Cox regression showing the hazard ratio (HR) of caesarean delivery comparing the defined BMI groups, with and without adjustment for covariates
| Total labour a | ||||
|---|---|---|---|---|
| Covariates | Crude HR | 95% CI | Adjusted HR | 95% CI |
| BMI | ||||
| < 25 | 1 | 1 | ||
| 25–29.9 | 1.39 | [1.06–1.81] | 1.28 | [0.97–1.69] |
| ≥ 30 | 1.94 | [1.40–2.69] | 1.80 | [1.28–2.54] |
| Height | ||||
| < 160 cm | 1 | 1 | ||
| 160–169 cm | 0.83 | [0.60–1.15] | 0.77 | [0.55–1.09] |
| 170–179 cm | 0.74 | [0.52–1.05] | 0.64 | [0.44–0.93] |
| ≥ 180 cm | 0.67 | [0.31–1.41] | 0.50 | [0.23–1.08] |
| Age | ||||
| < 25 | 1 | 1 | ||
| 25–29 | 0.99 | [0.72–1.37] | 0.97 | [0.69–1.37] |
| 30–34 | 1.22 | [0.88–1.68] | 1.31 | [0.94–1.84] |
| ≥ 35 | 1.57 | [1.08–2.29] | 1.82 | [1.22–2.69] |
| Birthweight | ||||
| < 3.0 kg | 1 | 1 | ||
| 3.0–3.5 kg | 0.89 | [0.56–1.41] | 0.98 | [0.59–1.61] |
| 3.5–4.0 kg | 1.03 | [0.67–1.59] | 1.13 | [0.71–1.82] |
| > 4.0 kg | 1.39 | [0.87–2.18] | 1.43 | [0.87–2.36] |
| Epidural | ||||
| No | 1 | 1 | ||
| Yes | 1.16 | [0.88–1.53] | 0.96 | [0.72–1.29] |
| Augmentation with oxytocin | ||||
| No | 1 | 1 | ||
| Yes | 1.21 | [0.85–1.72] | 0.96 | [0.65–1.42] |
| Induced labour | ||||
| No | 1 | 1 | ||
| Yes | 1.80 | [1.43–2.27] | 1.67 | [1.33–2.17] |
| Phase 1 | ||||
| Crude HR | 95% CI | Adjusted HR | 95% CI | |
| BMI | ||||
| < 25 | 1 | 1 | ||
| 25–29.9 | 1.68 | [1.07–2.66] | 1.55 | [0.97–2.48] |
| ≥ 30 | 1.56 | [0.86–2.84] | 1.56 | [0.84–2.89] |
| Phase 2 | ||||
| Crude HR | 95% CI | Adjusted HR | 95% CI | |
| BMI | ||||
| < 25 | 1 | 1 | ||
| 25–29.9 | 1.22 | [0.77–1.94] | 1.08 | [0.67–1.74] |
| ≥ 30 | 1.56 | [0.86–2.84] | 1.56 | [0.84–2.89] |
Phase 1 defined as the period of time from active labour until fully dilated
Phase 2 defined as the period of time from when fully dilated until actual birth. Vaginal deliveries censored
A HR > 1 illustrates an increased number of caesarean deliveries over time compared to the reference group; A shorter duration of labour. A HR < 1 illustrates a decreased number of vaginal deliveries over time compared to the reference group; A longer duration of labour
a77 women (4.1%) did not have duration measures recorded and were therefore not accounted for in analysis
Fig. 3Survival plot as a function of time from the onset of active labour until caesarean delivery. Event was defined as delivery. Women were censored at the time of vaginal delivery. Adjustments were made for maternal age, height, birth weight, labour induction, augmentation with oxytocin, and epidural analgesia. A hazard ratio (HR) >1 illustrates a shorter duration of labour while a HR <1 illustrates a longer duration of labour compared to the reference group consisting of normal-weight women